Literature DB >> 34642171

Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer.

Vikrant Kumar1, Kalpana Ramnarayanan1, Raghav Sundar1,2,3,4,5, Nisha Padmanabhan1, Supriya Srivastava6, Mayu Koiwa7, Tadahito Yasuda7, Vivien Koh2,8, Kie Kyon Huang1, Su Ting Tay1, Shamaine Wei Ting Ho1,8, Angie Lay Keng Tan1, Takatsugu Ishimoto7, Guowei Kim3,9, Asim Shabbir3,9, Qingfeng Chen10,11, Biyan Zhang12, Shengli Xu12,13, Kong-Peng Lam11,12,14, Huey Yew Jeffrey Lum15, Ming Teh15, Wei Peng Yong2,5,8, Jimmy Bok Yan So3,5,9,16, Patrick Tan1,5,8,13,17,18.   

Abstract

Gastric cancer heterogeneity represents a barrier to disease management. We generated a comprehensive single-cell atlas of gastric cancer (>200,000 cells) comprising 48 samples from 31 patients across clinical stages and histologic subtypes. We identified 34 distinct cell-lineage states including novel rare cell populations. Many lineage states exhibited distinct cancer-associated expression profiles, individually contributing to a combined tumor-wide molecular collage. We observed increased plasma cell proportions in diffuse-type tumors associated with epithelial-resident KLF2 and stage-wise accrual of cancer-associated fibroblast subpopulations marked by high INHBA and FAP coexpression. Single-cell comparisons between patient-derived organoids (PDO) and primary tumors highlighted inter- and intralineage similarities and differences, demarcating molecular boundaries of PDOs as experimental models. We complemented these findings by spatial transcriptomics, orthogonal validation in independent bulk RNA-sequencing cohorts, and functional demonstration using in vitro and in vivo models. Our results provide a high-resolution molecular resource of intra- and interpatient lineage states across distinct gastric cancer subtypes. SIGNIFICANCE: We profiled gastric malignancies at single-cell resolution and identified increased plasma cell proportions as a novel feature of diffuse-type tumors. We also uncovered distinct cancer-associated fibroblast subtypes with INHBA-FAP-high cell populations as predictors of poor clinical prognosis. Our findings highlight potential origins of deregulated cell states in the gastric tumor ecosystem. This article is highlighted in the In This Issue feature, p. 587. ©2021 The Authors; Published by the American Association for Cancer Research.

Entities:  

Mesh:

Year:  2022        PMID: 34642171     DOI: 10.1158/2159-8290.CD-21-0683

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  21 in total

1.  Reply to: Letter to editor on the article "Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy".

Authors:  Joe Yeong; Chong Boon Teo; Ryan Yong Kiat Tay; Benjamin Kye Jyn Tan; Yiong Huak Chan; Elizabeth C Smyth; Raghav Sundar
Journal:  Gastric Cancer       Date:  2022-09-24       Impact factor: 7.701

2.  Dysplastic Stem Cell Plasticity Functions as a Driving Force for Neoplastic Transformation of Precancerous Gastric Mucosa.

Authors:  Jimin Min; Changqing Zhang; R Jarrett Bliton; Brianna Caldwell; Leah Caplan; Kimberly S Presentation; Do-Joong Park; Seong-Ho Kong; Hye Seung Lee; M Kay Washington; Woo-Ho Kim; Ken S Lau; Scott T Magness; Hyuk-Joon Lee; Han-Kwang Yang; James R Goldenring; Eunyoung Choi
Journal:  Gastroenterology       Date:  2022-06-11       Impact factor: 33.883

3.  Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer.

Authors:  Xiaohuan Tang; Xiaolong Wu; Ting Guo; Fangzhou Jia; Ying Hu; Xiaofang Xing; Xiangyu Gao; Ziyu Li
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

Review 4.  Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma.

Authors:  Bingran Wang; Yizheng Xue; Wei Zhai
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

5.  DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma.

Authors:  Chien-Chang Kao; Yin-Lun Chang; Hui-Ying Liu; Sheng-Tang Wu; En Meng; Tai-Lung Cha; Guang-Huan Sun; Dah-Shyong Yu; Hao-Lun Luo
Journal:  Int J Mol Sci       Date:  2022-02-13       Impact factor: 5.923

Review 6.  Epigenetics of Dendritic Cells in Tumor Immunology.

Authors:  Gerard Godoy-Tena; Esteban Ballestar
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

7.  Editorial: Gastrointestinal Tumor Heterogeneity and Related Anti-Cancer Strategies.

Authors:  Rui Liao; Yu-Jun Shi; Michael D Chuong; Ju Cao
Journal:  Front Oncol       Date:  2022-04-11       Impact factor: 5.738

Review 8.  Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis.

Authors:  Yong Xiang Gwee; Daryl Kai Ann Chia; Jimmy So; Wim Ceelen; Wei Peng Yong; Patrick Tan; Chin-Ann Johnny Ong; Raghav Sundar
Journal:  J Clin Oncol       Date:  2022-06-01       Impact factor: 50.717

Review 9.  Discovering Immune-Mediated Mechanisms of Gastric Carcinogenesis Through Single-Cell RNA Sequencing.

Authors:  Stella G Hoft; Michelle D Pherson; Richard J DiPaolo
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

10.  Delineating Molecular Subtypes through Gene Set Variation Analysis Confers Therapeutic and Prognostic Capability in Gastric Cancer.

Authors:  Yuzhang Zhu; Ting Sun; Lei Zhang; Faming Fei; Yi Bao; Zhenzhen Gao
Journal:  Can J Gastroenterol Hepatol       Date:  2022-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.